Neuropeptide effects in the trigeminal system: Pathophysiology and clinical relevance in migraine

Keio Journal of Medicine

Volumn 60, Issue 3, 2011, Pages 82-89

  Messlinger, Karl ^a   Fischer, Michael J M ^b   Lennerz, Jochen K ^c  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

CGRP; Dura mater; Headache; Trigeminal ganglion; Trigeminal nucleus

Indexed keywords

CALCITONIN GENE RELATED PEPTIDE; CALCITONIN RECEPTOR LIKE RECEPTOR; NEUROKININ A; NEUROPEPTIDE Y; OLCEGEPANT; SUBSTANCE P; VASOACTIVE INTESTINAL POLYPEPTIDE; CALCITONIN GENE RELATED PEPTIDE RECEPTOR; PIPERAZINE DERIVATIVE; QUINAZOLINE DERIVATIVE;

BRAIN STEM; DRUG MECHANISM; DURA MATER; HUMAN; IN VITRO STUDY; IN VIVO STUDY; MAST CELL DEGRANULATION; MIGRAINE; NERVE CELL; NEUROPROTECTION; NEUROTRANSMISSION; NONHUMAN; PATHOGENESIS; PATHOPHYSIOLOGY; REVIEW; TRIGEMINAL NERVE; TRIGEMINAL NUCLEUS; TRIGEMINUS GANGLION; VASODILATATION; ANIMAL; CELL MEMBRANE POTENTIAL; DRUG ANTAGONISM; DRUG EFFECT; METABOLISM; PHYSIOLOGY;

ANIMALS; CALCITONIN GENE-RELATED PEPTIDE; DURA MATER; HUMANS; MEMBRANE POTENTIALS; MIGRAINE DISORDERS; NEUROKININ A; NEUROPEPTIDE Y; PIPERAZINES; QUINAZOLINES; RECEPTORS, CALCITONIN GENE-RELATED PEPTIDE; SUBSTANCE P; TRIGEMINAL GANGLION; TRIGEMINAL NUCLEUS, SPINAL; VASOACTIVE INTESTINAL PEPTIDE;

EID: 84856072587     PISSN: 00229717     EISSN: 18801293     Source Type: Journal    
DOI: 10.2302/kjm.60.82     Document Type: Review

References (39)

1. Brain SD, Cox HM: Neuropeptides and their receptors: Innovative science providing novel therapeutic targets. Br J Pharmacol 2006; 147(Suppl 1): S202-S211. [Medline] [CrossRef]
2. Holzer P: Neurogenic vasodilatation and plasma leakage in the skin. Gen Pharmacol 1998; 30: 5-11. [Medline]
3. Moskowitz MA: Neurogenic inflammation in the pathophysiology and treatment of migraine. Neurology 1993; 43: S16-S20. [Medline]
4. Buzzi MG, Dimitriadou V, Theoharides TC, Moskowitz MA: 5-Hydroxytryptamine receptor agonists for the abortive treatment of vascular headaches block mast cell, endothelial and platelet activation within the rat dura mater after trigeminal stimulation. Brain Res 1992; 583: 137-149. [Medline] [CrossRef]
5. Moussaoui SM, Philippe L, Le Prado N, Garret C: Inhibition of neurogenic inflammation in the meninges by a non-peptide NK1 receptor antagonist, RP 67580. Eur J Pharmacol 1993; 238: 421-424. [Medline] [CrossRef].
6. May A, Goadsby PJ: Substance P receptor antagonists in the therapy of migraine. Expert Opin Investig Drugs 2001; 10: 673-678. [Medline] [CrossRef]
7. Arulmani U, Maassenvandenbrink A, Villalon CM, Saxena PR: Calcitonin gene-related peptide and its role in migraine pathophysiology. Eur J Pharmacol 2004; 500: 315-330. [Medline] [CrossRef]
8. Keller JT, Marfurt CF: Peptidergic and serotoninergic innervation of the rat dura mater. J Comp Neurol 1991; 309: 515-534. [Med-line] [CrossRef]
9. Edvinsson L, Goadsby PJ: Neuropeptides in the cerebral circulation: Relevance to headache. Cephalalgia 1995; 15: 272-276. [Medline] [CrossRef]
10. Goadsby PJ, Edvinsson L: Human in vivo evidence for trigeminovascular activation in cluster headache. Neuropeptide changes and effects of acute attacks therapies. Brain 1994; 117: 427-434. [Medline] [CrossRef]
11. Ray BS, Wolff HG: Experimental studies on headache: Pain-sensitive structures of the head and their significance in headache. Arch Surg 1940; 41: 813-856.
12. Jansen-Olesen I, Mortensen A, Edvinsson L: Calcitonin generelated peptide is released from capsaicin-sensitive nerve fibres and induces vasodilatation of human cerebral arteries concomitant with activation of adenylyl cyclase. Cephalalgia 1996; 16: 310-316. [Medline] [CrossRef]
13. Edvinsson L, Gulbenkian S, Barroso CP: Cunha e Sa, Polak JM, Mortensen A, Jorgensen L, Jansen-Olesen I. Innervation of the human middle meningeal artery: Immunohistochemistry, ultrastructure, and role of endothelium for vasomotility. Peptides 1998; 19: 1213-1225. [Medline] [CrossRef]
14. Mesßlinger K, Hanesch U, Baumgartel M, Trost B, Schmidt RF: Innervation of the dura mater encephali of cat and rat: Ultrastructure and calcitonin gene-related peptide-like and substance Plike immunoreactivity. Anat Embryol (Berl) 1993; 188: 219-237. [Medline] [CrossRef]
15. Gupta S, Amrutkar DV, Mataji A, Salmasi H, Hay-Schmidt A, Sheykhzade M, Messlinger K, Olesen J, Jansen-Olesen I: Evidence for CGRP re-uptake in rat dura mater encephali. Br J Pharmacol 2010; 161: 1885-1898. [CrossRef]
16. Messlinger K, Hanesch U, Kurosawa M, Pawlak M, Schmidt RF: Calcitonin gene-related peptide released from dural nerve fibers mediates increase of meningeal blood flow in the rat. Can J Physiol Pharmacol 1995; 73: 1020-1024. [Medline] [CrossRef]
17. Ebersberger A, Averbeck B, Messlinger K, Reeh PW: Release of substance P, calcitonin gene-related peptide and prostaglandin E2 from rat dura mater encephali following electrical and chemical stimulation in vitro. Neuroscience 1999; 89: 901-907. [Medline] [CrossRef]
18. Goadsby PJ, Edvinsson L, Ekman R: Vasoactive peptide release in the extracerebral circulation of humans during migraine headache. Ann Neurol 1990; 28: 183-187. [Medline] [CrossRef]
19. Edvinsson L, Ekman R, Jansen I, McCulloch J, Uddman R: Calcitonin gene-related peptide and cerebral blood vessels: Distribution and vasomotor effects. J Cereb Blood Flow Metab 1987; 7: 720-728. [Medline] [CrossRef]
20. Edwards RM, Stack EJ, Trizna W: Calcitonin gene-related peptide stimulates adenylate cyclase and relaxes intracerebral arterioles. J Pharmacol Exp Ther 1991; 257: 1020-1024. [Medline]
21. Williamson DJ, Hargreaves RJ, Hill RG, Shepheard SL: Intravital microscope studies on the effects of neurokinin agonists and calcitonin gene-related peptide on dural vessel diameter in the anaesthetized rat. Cephalalgia 1997; 17: 518-524. [Medline] [Cross-Ref]
22. Kurosawa M, Messlinger K, Pawlak M, Schmidt RF: Increase of meningeal blood flow after electrical stimulation of rat dura mater encephali: Mediation by calcitonin gene-related peptide. Br J Pharmacol 1995; 114: 1397-1402. [Medline]
23. Tröltzsch M, Denekas T, Messlinger K: The Calcitonin gene-related peptide (CGRP) receptor antagonist BIBN4096BS reduces neurogenic increases in dural blood flow. Eur J Pharmacol 2007; 562: 103-110. [Medline] [CrossRef]
24. Poyner DR, Sexton PM, Marshall I, Smith DM, Quirion R, Born W, Muff R, Fischer JA, Foord SM: International Union of Pharmacology. XXXII. The mammalian calcitonin gene-related peptides, adrenomedullin, amylin, and calcitonin receptors. Pharmacol Rev 2002; 54: 233-246. [Medline] [CrossRef]
25. Levy D, Strassman AM: Distinct sensitizing effects of the CAMP-PKA second messenger cascade on rat dural mechanonociceptors. J Physiol 2002; 538: 483-493. [Medline] [CrossRef]
26. Levy D, Burstein R, Strassman AM: Calcitonin gene-related peptide does not excite or sensitize meningeal nociceptors: Implications for the pathophysiology of migraine. Ann Neurol 2005; 58: 698-705. [Medline] [CrossRef]
27. Lennerz JK, Ruhle V, Ceppa EP, Neuhuber WL, Bunnett NW, Grady EF, Messlinger K: Calcitonin receptor-like receptor (CLR), receptor activity modifying protein 1 (RAMP1), and calcitonin gene-related peptide (CGRP) immunoreactivity in the rat trigeminovascular system: Differences between peripheral and central CGRP receptor distribution. J Comp Neurol 2008; 507: 1277-1299. [Medline] [CrossRef]
28. Dimlich RV, Keller JT, Strauss TA, Fritts MJ: Linear arrays of homogeneous mast cells in the dura mater of the rat. J Neurocytol 1991; 20: 485-503. [Medline] [CrossRef]
29. Levy D, Burstein R, Kainz V, Jakubowski M, Strassman AM: Mast cell degranulation activates a pain pathway underlying migraine headache. Pain 2007; 130: 166-176. [Medline] [CrossRef]
30. Schwenger N, Dux M, De Col R, Carr R, Messlinger K: Interaction of calcitonin gene-related peptide, nitric oxide and histamine release in neurogenic blood flow and afferent activation in the rat cranial dura mater. Cephalalgia 2007; 27: 481-491. [Medline] [CrossRef]
31. Segond v Banchet G, Pastor A, Biskup C, Schlegel C, Benndorf K, Schaible HG: Localization of functional calcitonin gene-related peptide binding sites in a subpopulation of cultured dorsal root ganglion neurons. Neuroscience 2002; 110: 131-145. [Medline] [CrossRef]
32. Zhang Z, Winborn CS: Marquez de PB, Russo AF. Sensitization of calcitonin gene-related peptide receptors by receptor activitymodifying protein-1 in the trigeminal ganglion. J Neurosci 2007; 27: 2693-2703. [Medline] [CrossRef]
33. Li J, Vause CV, Durham PL: Calcitonin gene-related peptide stimulation of nitric oxide synthesis and release from trigeminal ganglion glial cells. Brain Res 2008; 1196: 22-32. [Medline] [CrossRef]
34. Fischer MJ, Koulchitsky S, Messlinger K: The nonpeptide calcitonin gene-related peptide receptor antagonist BIBN4096BS lowers the activity of neurons with meningeal input in the rat spinal trigeminal nucleus. J Neurosci 2005; 25: 5877-5883. [Medline] [CrossRef]
35. Sixt ML, Messlinger K, Fischer MJ: Calcitonin gene-related peptide receptor antagonist olcegepant acts in the spinal trigeminal nucleus. Brain 2009; 132: 3134-3141. [Medline] [CrossRef]
36. Storer RJ, Akerman S, Goadsby PJ: Calcitonin gene-related peptide (CGRP) modulates nociceptive trigeminovascular transmission in the cat. Br J Pharmacol 2004; 142: 1171-1181. [Medline] [CrossRef]
37. Meng J, Ovsepian SV, Wang J, Pickering M, Sasse A, Aoki KR, Lawrence GW, Dolly JO: Activation of TRPV1 mediates calcitonin gene-related peptide release, which excites trigeminal sensory neurons and is attenuated by a retargeted botulinum toxin with anti-nociceptive potential. J Neurosci 2009; 29: 4981-4992. [Medline] [CrossRef]
38. Ho TW, Mannix LK, Fan X, Assaid C, Furtek C, Jones CJ, Lines CR, Rapoport AM: Randomized controlled trial of an oral CGRP antagonist, MK-0974, in acute treatment of migraine. Neurology 2008; 70: 1304-1312. [Medline] [CrossRef]
39. Olesen J, Diener HC, Husstedt IW, Goadsby PJ, Hall D, Meier U, Pollentier S, Lesko LM: Calcitonin gene-related peptide receptor antagonist BIBN 4096 BS for the acute treatment of migraine. N Engl J Med 2004; 350: 1104-1110. [Medline] [CrossRef].